F1SCHEDULE 3AMONITORING FOR INDICATIVE DOSE AND ANALYTICAL PERFORMANCE CHARACTERISTICS

Annotations:
Amendments (Textual)

Screening for gross alpha activity and gross beta activityF13

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .